Send to

Choose Destination
See comment in PubMed Commons below
Acta Neurol Scand. 2012 Aug;126(2):77-97. doi: 10.1111/j.1600-0404.2012.01661.x. Epub 2012 Mar 19.

Neurological features of Fabry disease: clinical, pathophysiological aspects and therapy.

Author information

Department of Emergency Neurology, IRCCS C. Mondino National Institute of Neurology Foundation, Pavia, Italy.


Fabry disease is a multisystem, X-linked, lysosomal storage disorder caused by a mutation in the GLA gene on chromosome Xq22 resulting in alpha-galactosidase A enzyme (α-Gal A) deficiency. Neurological manifestations other than cerebrovascular accidents include small fibre neuropathy and dysautonomic disorders, which may be the presenting clinical features in a proportion of patients. An atypical disease onset may be misdiagnosed until the emergence of a more typical clinical picture, characterized by chronic renal and cardiac failure. Thus, neurologists should consider Fabry disease in differential diagnosis and provide an appropriate diagnostic work up. This review focuses on central and peripheral nervous system involving available diagnostic tools and diagnostic work up in Fabry disease. It also covers the most recent evidence regarding enzyme replacement therapy.

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center